ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Biological Availability

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Biochemical Phenomena, Metabolism, and Nutrition ∟ Metabolism ∟ Pharmacokinetics ∟ Biological Availability 4 coordinate concepts ∟ Area Under Curve \| ∟ Biotransformation \| ∟ Therapeutic Equivalency \| ∟ Tissue Distribution Medical Subject Headings (MeSH) ∟ Chemical and Pharmacologic Phenomena ∟ Biopharmaceutics ∟ Pharmacokinetics ∟ Biological Availability 4 coordinate concepts ∟ Area Under Curve \| ∟ Biotransformation \| ∟ Therapeutic Equivalency \| ∟ Tissue Distribution X
Broader terms:	Medical Subject Headings (MeSH) ∟ Biochemical Phenomena, Metabolism, and Nutrition ∟ Metabolism ∟ Pharmacokinetics ∟ Biological Availability Medical Subject Headings (MeSH) ∟ Chemical and Pharmacologic Phenomena ∟ Biopharmaceutics ∟ Pharmacokinetics ∟ Biological Availability Pharmacokinetics > Metabolism > Biochemical Phenomena, Metabolism, and Nutrition > Medical Subject Headings (MeSH) Pharmacokinetics > Biopharmaceutics > Chemical and Pharmacologic Phenomena > Medical Subject Headings (MeSH) X
Annotation:	NIM with specific drug /pharmacokin (IM); no qualif; DF: BIOL AVAILABILITY X
History note:	Biopharmaceutics (1966-1974) \| Drug Compounding (1966-1969) \| Drugs (1966-1969) \| Pharmacology (1966-1969)X
historyNote*:	79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; PHYSIOLOGIC AVAILABILITY was see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOPHARMACEUTICS 1970-79 and see under BIOLOGICAL AVAILABILITY 1980-86 X
onlineNote*:	use BIOLOGICAL AVAILABILITY to search AVAILABILITY EQUIVALENCY 1980-86, BIOLOGIC AVAILABILITY & PHYSIOLOGIC AVAILABILITY 1975-79, & BIOPHARMACEUTICS 1970-74 X
publicMeSHNote*:	79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; AVAILABILITY EQUIVALENCY & PHYSIOLOGIC AVAILABILITY were see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOLOGICAL AVAILABILITY 1980-86 X
Scope note:	The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. X
activeMeSHYear*:	2005 \| 2006 \| 2007X
dateCreated*:	1999-01-01X
dateEstablished*:	1979-01-01X
dateRevised*:	2004-07-07X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	NLMX
Type:	Concept X
Coordinate terms:	Area Under Curve \| Biotransformation \| Therapeutic Equivalency \| Tissue Distribution X
URI:	X
Labels and equivalent concepts:	Biologinen availabiliteetti (fi) Biologisk tillgänglighet (sv) Biotillgänglighet (sv, replaced) Physiologic Availability (en, replaced) Biologic Availability (en, replaced) Bioavailability (en, replaced) Availability, Biological (en, replaced) Availability, Physiologic (en, replaced) Availability, Biologic (en, replaced) X
Share:	X